Press release
Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research
Partnership aims to destigmatize androgenetic alopecia and highlight the need for new therapeutic options that address the root cause of disease Donovan to
About this update from Absci Corporation
[{"type":"text","content":"Partnership aims to destigmatize androgenetic alopecia and highlight the need for new therapeutic options that address the root cause of disease Donovan to share his personal journey at Absci’s upcoming Key Opinion Leader seminar VANCOUVER, Wash. and NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced a partnership with U.S. soccer legend Landon Donovan to elevate the voices of those living with androgenetic alopecia (AGA) and shine a light on the emotional impact of hair loss. Donovan will join Absci’s virtual KOL seminar on Thursday, December 11 to speak about his patient experience and the need for better treatment options, providing patient-driven context for the design and development of the investigational antibody, ABS-201. “For years, I felt like I had to suffer in silence because hair loss is often dismissed as just a vanity issue. But the reality is that losing your hair can feel like losing a piece of your identity,” said Landon Donovan, former U.S. Men’s National Team captain. “I know the frustration of looking in the mirror, trying products that don’t work, and feeling like there is no real solution. I’m sharing my story to let others know they aren’t alone, and to support the work Absci is doing to finally bring a science-first approach to a condition that affects so many of us.” “We believe that developing breakthrough medicines starts with listening to the people who need them,” said Sean McClain, Founder and CEO of Absci. “Landon’s story is a powerful reminder that behind every data point is a person struggling with self-confidence and mental health. This partnership reinforces our commitment to improving the lives of patients who have been waiting too long for innovation.” Absci will be hosting a virtual seminar on Thursday, December 11 with leading dermatology and hair research experts to discuss the anticipated clinical development path, market opportunity, and differentiated profile of AI designed antibody ABS-201. The company will also disclose additional, new human ex vivo data that further support the PRLR mechanism of action underlying this program. Landon Donovan will join the seminar to share his personal struggles with hair loss and the human impact of androgenet...